Open Payments

RADY CHILDRENS HOSPITAL - SAN DIEGO

Type
Teaching hospital
Where
SAN DIEGO, CA
Medicare CCN
053303
Received
$622,090 in 244 records, 2019 ($135,425 general, $486,664 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2019General payment71$135,425
2019Research payment173$486,664

By company

CompanyRecordsAmountYears
Merck Sharp & Dohme LLC126$230,0092019
Soleno Therapeutics, Inc.1$170,6282019
Becton, Dickinson and Company1$40,4762019
PFIZER INC.6$27,7252019
TOLMAR, INC.2$26,0632019
Alexion Pharmaceuticals, Inc.2$22,0002019
KARL STORZ Endoscopy-America44$14,8292019
Medtronic USA, Inc.2$14,1242019
Daiichi Sankyo Inc.6$13,6092019
Grifols Therapeutics LLC1$10,3592019
OrthoPediatrics Corp.1$10,0002019
Incyte Corporation30$8,8502019
Linvatec Corporation2$5,8072019
Regeneron Healthcare Solutions, Inc.1$5,0002019
Eli Lilly and Company2$4,4182019
Amgen Inc.1$3,5002019
Pierre Fabre Pharmaceuticals, Inc.1$3,5002019
MED-EL Corporation2$1,7502019
Zimmer Biomet Holdings, Inc.1$1,2572019
ABBVIE INC.1$1,0002019
Electromed, Inc.1$1,0002019
Advanced Respiratory, Inc1$1,0002019
Cochlear Americas1$1,0002019
Genentech USA, Inc.1$1,0002019
Gilead Sciences, Inc.1$1,0002019
Advanced Bionics, LLC1$1,0002019
180 Medical, Inc.1$5002019
Hollister Incorporated1$2132019
Merge Healthcare Incorporated1$1712019
Catalent Pharma Solutions, LLC1$1502019
GenMark Diagnostics, Inc.1$1422019

By nature of payment

NatureRecordsAmount
Research payment173$486,664
Compensation for services other than consulting, including serving as faculty or as a speaker at a v1$40,476
Education3$33,500
Space rental or facility fees (teaching hospital only)13$32,124
Gift44$14,829
Grant6$13,815
Food and Beverage3$528
Charitable Contribution1$150

Records

DateCompanyAmountNatureFormProductStudyYear
2019-12-31Linvatec Corporation$1,014GrantIn-kind items and servicesMICROFREE Device, ORTHOPEDIC SURGERY2019
2019-12-18Merck Sharp & Dohme LLC$8,507Research paymentCash or cash equivalentBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-12-14180 Medical, Inc.$500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2019
2019-12-12PFIZER INC.$3,772Research paymentIn-kind items and servicesLIPITOR Drug, CARDIOVASCULAR;METABOLIC DISEASELIPITOR IN INFANTS AND CHILDREN WITH CORONARY ARTERY ABNORMALITIES IN ACUTE KAWASAKI DISEASE2019
2019-12-11Merck Sharp & Dohme LLC$10,000Research paymentCash or cash equivalentNOXAFIL Drug, INFECTIOUS DISEASEA Phase 2, Open-Label, Non-Comparative Clinical Trial to Study the Safety and Efficacy of Posaconazole POS, MK-5592 in P2019
2019-12-09KARL STORZ Endoscopy-America$417GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-12-09Merck Sharp & Dohme LLC$70Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$35Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$29Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$29Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$29Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$20Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$16Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$13Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$9Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$8Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$6Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$3Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$3Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$2Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-09Merck Sharp & Dohme LLC$1Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-12-06KARL STORZ Endoscopy-America$1,258GiftIn-kind items and servicesTELESCOPE, HOPKINS, STRAIGHT Device, ENT2019
2019-12-06KARL STORZ Endoscopy-America$426GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-12-06KARL STORZ Endoscopy-America$286GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-12-06KARL STORZ Endoscopy-America$79GiftIn-kind items and servicesADAPTOR,LOCKING.F/27015, Device, ENT2019
2019-12-03Incyte Corporation$1,583Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-11-26KARL STORZ Endoscopy-America$186GiftIn-kind items and servicesTUBE,BRONCH,'DOESEL-HUZLY' Device, ENT2019
2019-11-22KARL STORZ Endoscopy-America$144GiftIn-kind items and servicesTUBE,UNIVERSAL BRONCH.W/O Device, ENT2019
2019-11-19Merck Sharp & Dohme LLC$39Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-11-12Merck Sharp & Dohme LLC$391Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-11-12KARL STORZ Endoscopy-America$228GiftIn-kind items and servicesHOPKINS 30 TELESCOPE, AUTOCLAVABLE Device, ODONTOLOGY2019
2019-11-12Merck Sharp & Dohme LLC$134Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-11-08Merck Sharp & Dohme LLC$1,520Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-11-08Incyte Corporation$35Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-11-08Incyte Corporation$2Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-11-07KARL STORZ Endoscopy-America$1,258GiftIn-kind items and servicesTELESCOPE, HOPKINS, STRAIGHT Device, ENT2019
2019-11-07KARL STORZ Endoscopy-America$185GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-11-07KARL STORZ Endoscopy-America$117GiftIn-kind items and servicesCARRIER,FIBER OPTIC LIGHT. Device, ENT2019
2019-11-07KARL STORZ Endoscopy-America$79GiftIn-kind items and servicesADAPTOR,LOCKING.F/27015, Device, ENT2019
2019-11-07KARL STORZ Endoscopy-America$30GiftIn-kind items and servicesTUBE,INSERTABLE SUCTION,F/ Device, ENT2019
2019-11-07KARL STORZ Endoscopy-America$29GiftIn-kind items and servicesCANNULA,INJECTION. F/POSITIVE Device, ENT2019
2019-11-06KARL STORZ Endoscopy-America$196GiftIn-kind items and servicesHOPKINS II Telescope 0, 2.7 mm, 18 cm Device, ENT2019
2019-11-05Incyte Corporation$6,346Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-11-05KARL STORZ Endoscopy-America$210GiftIn-kind items and servicesCLIP,STEINER-BENJAMIN-HAVAS, Device, ENT2019
2019-11-05KARL STORZ Endoscopy-America$196GiftIn-kind items and servicesTELESCOPE, HOPKINS II LATERAL, 70', Device, ENT2019
2019-11-05KARL STORZ Endoscopy-America$196GiftIn-kind items and servicesTELESCOPE, HOPKINS,30'AUTOCLAV Device, GYNECOLOGY2019
2019-11-05KARL STORZ Endoscopy-America$121GiftIn-kind items and servicesCONTAINER, 2 RIGID SCOPES, 4MM X 18CM Device, CLEANING, STERILIZATION, CARE2019
2019-11-05KARL STORZ Endoscopy-America$121GiftIn-kind items and servicesCONTAINER, 2 RIGID SCOPES, 4MM X 18CM Device, CLEANING, STERILIZATION, CARE2019
2019-11-04Merck Sharp & Dohme LLC$15,170Research paymentCash or cash equivalentBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-11-04KARL STORZ Endoscopy-America$571GiftIn-kind items and servicesTUBE,BRONCH,'DOESEL-HUZLY' Device, ENT2019
2019-11-04KARL STORZ Endoscopy-America$381GiftIn-kind items and servicesTUBE,BRONCH,'DOESEL-HUZLY' Device, ENT2019
2019-11-04KARL STORZ Endoscopy-America$225GiftIn-kind items and servicesTELESCOPE, HOPKINS, STRAIGHT Device, ENT2019
2019-11-04KARL STORZ Endoscopy-America$225GiftIn-kind items and servicesTELESCOPE, HOPKINS, STRAIGHT Device, ENT2019
2019-11-04KARL STORZ Endoscopy-America$190GiftIn-kind items and servicesTUBE,BRONCH,'DOESEL-HUZLY' Device, ENT2019
2019-11-04KARL STORZ Endoscopy-America$111GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-11-04KARL STORZ Endoscopy-America$21GiftIn-kind items and servicesTONSIL AND ADENOID SET Device, ENT2019
2019-11-01KARL STORZ Endoscopy-America$573GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-11-01KARL STORZ Endoscopy-America$102GiftIn-kind items and servicesTONSIL AND ADENOID SET Device, ENT2019
2019-10-30Merck Sharp & Dohme LLC$3,250Research paymentCash or cash equivalentBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-29KARL STORZ Endoscopy-America$516GiftIn-kind items and servicesFORCEPS,CIRCULAR CUP BIOPSY. Device, ENT2019
2019-10-29KARL STORZ Endoscopy-America$196GiftIn-kind items and servicesHOPKINS II TELESCOPE 30, 2.7MM, 18CM Device, ENT2019
2019-10-28Merck Sharp & Dohme LLC$100Research paymentIn-kind items and servicesZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-10-28Merck Sharp & Dohme LLC$60Research paymentIn-kind items and servicesZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-10-25Merck Sharp & Dohme LLC$9,159Research paymentCash or cash equivalentBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-25KARL STORZ Endoscopy-America$395GiftIn-kind items and servicesOPTICAL FORCEPS Device, ENT2019
2019-10-24KARL STORZ Endoscopy-America$4,131GiftIn-kind items and servicesFORCEPS,CIRCULAR CUP BIOPSY. Device, ENT2019
2019-10-24KARL STORZ Endoscopy-America$517GiftIn-kind items and servicesADAPTOR,LOCKING.F/27015, Device, ENT2019
2019-10-24KARL STORZ Endoscopy-America$50GiftIn-kind items and servicesTUBE,RIGID SUCTION.W/THUMB Device, ENT2019
2019-10-24KARL STORZ Endoscopy-America$13GiftIn-kind items and servicesFORCEPS, CRILE HAEMOSTATIC, Device, ENT2019
2019-10-23KARL STORZ Endoscopy-America$169GiftIn-kind items and servicesTUBE,WHISTLE TIP SUCTION. Device, ENT2019
2019-10-22KARL STORZ Endoscopy-America$258GiftIn-kind items and servicesFORCEPS,CIRCULAR CUP BIOPSY. Device, ENT2019
2019-10-22KARL STORZ Endoscopy-America$190GiftIn-kind items and servicesADAPTOR,LOCKING.F/27015, Device, ENT2019
2019-10-22Merge Healthcare Incorporated$171Food and Beverage (5 payments)Cash or cash equivalent Device, Medical Imaging2019
2019-10-22KARL STORZ Endoscopy-America$74GiftIn-kind items and servicesTONSIL AND ADENOID SET Device, ENT2019
2019-10-22KARL STORZ Endoscopy-America$64GiftIn-kind items and servicesTONSIL AND ADENOID SET Device, ENT2019
2019-10-22KARL STORZ Endoscopy-America$33GiftIn-kind items and servicesCARRIER, FIBER OPTIC LIGHT, Device, ENT2019
2019-10-22KARL STORZ Endoscopy-America$13GiftIn-kind items and servicesFORCEPS, CRILE HAEMOSTATIC, Device, ENT2019
2019-10-09Merck Sharp & Dohme LLC$1Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-10-09Merck Sharp & Dohme LLC$1Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-10-08PFIZER INC.$2,152Research paymentIn-kind items and servicesZAVICEFTA NEONATAL SEPSIS TRIAL2019
2019-10-08Merck Sharp & Dohme LLC$48Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-08Merck Sharp & Dohme LLC$39Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-08Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-08Merck Sharp & Dohme LLC$29Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-08Merck Sharp & Dohme LLC$3Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-10-08Merck Sharp & Dohme LLC$1Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-09-27Merck Sharp & Dohme LLC$284Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-09-26Merck Sharp & Dohme LLC$64Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-09-25Merck Sharp & Dohme LLC$23,860Research paymentCash or cash equivalentRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-09-18MED-EL Corporation$1,000GrantCash or cash equivalentMED-EL Maestro Cochlear Implant System Device, Cochlear Implant2019
2019-09-16Merck Sharp & Dohme LLC$10,500Research paymentCash or cash equivalentRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-09-13Merck Sharp & Dohme LLC$453Research paymentIn-kind items and servicesSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-09-12Merck Sharp & Dohme LLC$494Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-09-11Merck Sharp & Dohme LLC$1,154Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 2,3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and 2019
2019-09-10Incyte Corporation$49Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-09-10Incyte Corporation$42Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-09-10Merck Sharp & Dohme LLC$39Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-09-10Incyte Corporation$24Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-09-10Merck Sharp & Dohme LLC$0Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-09-10Merck Sharp & Dohme LLC$0Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-09-09Merck Sharp & Dohme LLC$2,385Research paymentCash or cash equivalentRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-09-09Merck Sharp & Dohme LLC$1,136Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-09-05Daiichi Sankyo Inc.$1,062Research paymentCash or cash equivalentWEL-A-U3072019
2019-08-21Merck Sharp & Dohme LLC$2,060Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-08-21Merck Sharp & Dohme LLC$2Research paymentIn-kind items and servicesSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-08-19Merck Sharp & Dohme LLC$2,060Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-08-14Merck Sharp & Dohme LLC$2,112Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-08-13Cochlear Americas$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentNucleus Device, Implantable hearing solution2019
2019-08-09Merck Sharp & Dohme LLC$4,900Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-08-08Merck Sharp & Dohme LLC$118Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$35Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$30Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$24Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$20Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$19Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$12Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$12Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$12Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$6Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$4Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$3Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$3Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-08Merck Sharp & Dohme LLC$2Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-08-01Zimmer Biomet Holdings, Inc.$1,257GrantCash or cash equivalentGrants Device, General2019
2019-07-30Advanced Bionics, LLC$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentHiResolution Bionic Ear System Device, OTOLARYNGOLOGY2019
2019-07-26Merck Sharp & Dohme LLC$760Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-07-26Merck Sharp & Dohme LLC$760Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-07-25Merck Sharp & Dohme LLC$90Research paymentIn-kind items and servicesZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-07-25Merck Sharp & Dohme LLC$11Research paymentIn-kind items and servicesZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-07-15Merck Sharp & Dohme LLC$2,840Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-07-11Daiichi Sankyo Inc.$283Research paymentCash or cash equivalentWEL-A-U3072019
2019-07-10Incyte Corporation$76Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-07-10Incyte Corporation$76Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-07-10Incyte Corporation$76Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-07-10Incyte Corporation$76Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-07-10Incyte Corporation$58Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-07-10Incyte Corporation$23Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-07-03Catalent Pharma Solutions, LLC$150Charitable ContributionCash or cash equivalent2019
2019-07-01Genentech USA, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentPulmozyme Biological, Virology & Specialty Care2019
2019-06-25Merck Sharp & Dohme LLC$78Research paymentIn-kind items and servicesZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-06-21Merck Sharp & Dohme LLC$723Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-06-19Merck Sharp & Dohme LLC$963Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-06-17Merck Sharp & Dohme LLC$1,804Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-06-17Merck Sharp & Dohme LLC$1,520Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-06-17Merck Sharp & Dohme LLC$760Research paymentCash or cash equivalentRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-06-17Merck Sharp & Dohme LLC$284Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-06-13Daiichi Sankyo Inc.$3,969Research paymentCash or cash equivalentWEL-A-U3072019
2019-06-13ABBVIE INC.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentCreon Drug, Endocrinology2019
2019-06-12Merck Sharp & Dohme LLC$3,150Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEPhase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-Day Comparator in Subjects 12 to 18 Years with c2019
2019-06-12Merck Sharp & Dohme LLC$1,260Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEPhase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-Day Comparator in Subjects 12 to 18 Years with c2019
2019-06-12Merck Sharp & Dohme LLC$1,000Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEPhase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-Day Comparator in Subjects 12 to 18 Years with c2019
2019-06-12Merck Sharp & Dohme LLC$630Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEPhase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-Day Comparator in Subjects 12 to 18 Years with c2019
2019-06-10Merck Sharp & Dohme LLC$2,840Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-06-07Merck Sharp & Dohme LLC$4,316Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-06-06Daiichi Sankyo Inc.$2,551Research paymentCash or cash equivalentWEL-A-U3072019
2019-06-05Gilead Sciences, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2019
2019-06-04Becton, Dickinson and Company$40,476Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2019
2019-05-24PFIZER INC.$7,200Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESTHE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCE2019
2019-05-24PFIZER INC.$4,400Research paymentCash or cash equivalentPREVNAR - 13 Biological, VACCINESTHE UNITED STATES PEDIATRIC MULTICENTER PNEUMOCOCCAL SURVEILLANCE2019
2019-05-14Electromed, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentSMARTVEST Device, HFCWO2019
2019-05-09Merck Sharp & Dohme LLC$167Research paymentIn-kind items and servicesSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-05-08Merck Sharp & Dohme LLC$277Research paymentIn-kind items and servicesSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-05-08Merck Sharp & Dohme LLC$49Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-05-08Incyte Corporation$35Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-05-08Incyte Corporation$24Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-05-08Incyte Corporation$24Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-05-08Merck Sharp & Dohme LLC$19Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-05-08Merck Sharp & Dohme LLC$18Research paymentIn-kind items and servicesRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-05-08Incyte Corporation$12Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-05-08Incyte Corporation$1Research paymentCash or cash equivalentA Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr2019
2019-04-26GenMark Diagnostics, Inc.$142Food and Beverage (2 payments)In-kind items and services2019
2019-04-16Merck Sharp & Dohme LLC$35Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-04-15Merck Sharp & Dohme LLC$760Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial To Study The Safety and Ef2019
2019-04-15Merck Sharp & Dohme LLC$710Research paymentCash or cash equivalentRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-04-11Daiichi Sankyo Inc.$2,290Research paymentCash or cash equivalentWelchol Drug, MetabolismWEL-A-U3072019
2019-04-10Merck Sharp & Dohme LLC$5,090Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-04-10Regeneron Healthcare Solutions, Inc.$5,000GrantCash or cash equivalentDUPIXENT Biological, INFLAMMATION AND IMMUNOLOGY2019
2019-04-09OrthoPediatrics Corp.$10,000EducationCash or cash equivalentOrthopediatric Implants Device, Orthopediatric Implants2019
2019-04-08Eli Lilly and Company$884Research paymentIn-kind items and servicesTRULICITY Drug, DiabetesA RANDOMIZED, DOUBLE-BLIND STUDY WITH AN OPEN-LABEL EXTENSION COMPARING THE EFFECT OF ONCE-WEEKLY DULAGLUTIDE WITH PLACE2019
2019-04-08Merck Sharp & Dohme LLC$758Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-04-08Merck Sharp & Dohme LLC$494Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-04-08Merck Sharp & Dohme LLC$391Research paymentIn-kind items and servicesBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-04-08Incyte Corporation$71Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-08Incyte Corporation$62Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-08Incyte Corporation$20Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-08Incyte Corporation$7Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-08Incyte Corporation$6Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-08Incyte Corporation$3Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-08Incyte Corporation$2Research paymentCash or cash equivalentAn Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis2019
2019-04-05Eli Lilly and Company$3,534Research paymentIn-kind items and servicesA PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG WITH AN OPEN-LABEL POSTPRANDIAL LY900014 TREAT2019
2019-04-05Merck Sharp & Dohme LLC$2,820Research paymentCash or cash equivalentRECARBRIO Drug, INFECTIOUS DISEASEA Phase 1b, Open label, Single dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of MK-7655A in Chil2019
2019-04-04MED-EL Corporation$750GrantCash or cash equivalentMED-EL Maestro Cochlear Implant System Device, Cochlear Implant2019
2019-03-28Medtronic USA, Inc.$3,402Space rental or facility fees (teaching hospital only)Cash or cash equivalentMazorX - Renaissance Device, Enabling2019
2019-03-27Merck Sharp & Dohme LLC$10,000Research paymentCash or cash equivalentBRIDION Drug, NEUROSCIENCEA Phase 4 Double-Blinded, Randomized, Active Comparator-ControlledClinical Trial to Study the Efficacy, Safety, and Phar2019
2019-03-23Merck Sharp & Dohme LLC$1,020Research paymentIn-kind items and servicesZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019
2019-03-21Merck Sharp & Dohme LLC$3,788Research paymentCash or cash equivalentSIVEXTRO Drug, INFECTIOUS DISEASEPhase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-Day Comparator in Subjects 12 to 18 Years with c2019
2019-03-21Merck Sharp & Dohme LLC$167Research paymentIn-kind items and servicesSIVEXTRO Drug, INFECTIOUS DISEASEA Phase III Randomized, Active-comparator-controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 Tedizoli2019
2019-03-15Daiichi Sankyo Inc.$3,453Research paymentCash or cash equivalentWelchol Drug, MetabolismWEL-A-U3072019
2019-03-15Merck Sharp & Dohme LLC$2,385Research paymentCash or cash equivalentZERBAXA Drug, INFECTIOUS DISEASEA Phase 2 Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Eff2019

The latest 200 records of 244.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

San Diego CountySan Diego city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In San Diego, CA, county San Diego County, CA, state California; placed by its city name.

MeasurePlace (city or town)
San Diego, CA
County
San Diego County, CA
State
California
Population B010031,389,5263,288,77439,287,377
Population, 2020 census P11,386,9323,298,63439,538,223
Median age B0100236.237.337.9
Under 18 B0100118.4%20.9%22.0%
65 and over B0100114.6%15.4%15.7%
Households B11001530,4121,171,27813,548,091
Foreign born B0500225.1%22.8%27.0%
Median household income B19013$108,077$106,268$99,122
Median family income B19113$128,006$122,377$113,346
Per capita income B19301$57,083$51,976$49,513
Poverty rate B1700111.0%10.3%12.0%
Unemployment rate B230256.0%6.1%6.6%
Civilian labor force B23025755,8931,689,38420,068,466
Mean commute (minutes) B0801323.525.528.7
Bachelor's degree or higher B1500351.0%43.2%37.1%
Housing units B25001568,6681,250,64114,644,735
Owner-occupied B2500347.3%54.6%55.9%
Renters B2500352.7%45.4%44.1%
Median home value B25077$906,700$854,700$734,700
Median gross rent B25064$2,313$2,246$2,036
White, not Hispanic B0300240.9%42.4%33.8%
Black B030025.3%4.4%5.2%
Hispanic or Latino B0300229.8%34.6%40.2%
Asian B0300217.3%12.1%15.3%
American Indian and Alaska Native B030020.2%0.2%0.3%

Economy now FRED unemployment 5.1% in Sep 2026 (5.5% a year earlier); per capita personal income $90,957 in 2025, up 30% in five years (+4.3% after inflation); Unemployment rate: 5.5% in Sep 2016 to 5.1% in Sep 2026; low 3.8%, high 16.1% the state; Source: FRED, Federal Reserve Bank of St. Louis.

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in San Diego, CA.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.